Search
Now showing items 11-20 of 36
Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis
(2019-05)
Introduction: Pharmacotherapy plays an important role in the treatment of major depression. At the initiation of antidepressant treatment, both improvement of symptoms in the short term and relapse prevention in the long ...
Disrupting the power balance between doctors and patients in the digital era
(2021-01)
The primary way of identifying symptoms of impending disease, and when it is time to seek care, relies heavily on a patient's own perception of how they feel. This reliance on a disease reaching a threshold at which ...
Online mood monitoring in treatment-resistant depression: qualitative study of patients' perspectives in the NHS
(2020-01)
Aims and method True Colours is an automated symptom monitoring programme
used by National Health Service psychiatric services. This study explored whether
patients with unipolar treatment-resistant depression (TRD) found ...
Introducing artificial intelligence in acute psychiatric inpatient care: qualitative study of its use to conduct nursing observations.
(2020-02)
Background All patients admitted to an acute inpatient mental health unit must have nursing observations carried out at night either hourly or every 15 minutes, to ascertain that they are safe and breathing. However, while ...
How pharmacist prescribers can help meet the mental health consequences of COVID-19
(2020-11)
We suggest that Mental Health Trusts
should urgently develop prescribing roles
for specialist mental health pharmacists,
which are integrated within mental health
teams. In these roles, prescribing pharmacists can ...
Six-month Neurological and Psychiatric Outcomes in 236,379 Survivors of COVID-19
(2021-01)
Background. Neurological and psychiatric sequelae of COVID-19 have been reported, but
there are limited data on incidence rates and relative risks.
Methods. Using retrospective cohort studies and time-to-event analysis, ...
Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA
(2020)
Background
Adverse mental health consequences of COVID-19, including anxiety and depression, have been widely predicted but not yet accurately measured. There are a range of physical health risk factors for COVID-19, but ...
A web-based clinical decision tool to support treatment decision-making in psychiatry: a pilot focus group study with clinicians, patients and carers
(2017)
Background
Treatment decision tools have been developed in many fields of medicine, including psychiatry, however benefits for patients have not been sustained once the support is withdrawn. We have developed a web-based ...
A narrative review of the success of intramuscular gluteal injections and its impact in psychiatry
(2018-07)
There are 12 billion injections given worldwide every year. For many injections, the intramuscular route is favoured over the subcutaneous route due to the increased vascularity of muscle tissue and the corresponding ...
Cerebral venous thrombosis: a retrospective cohort study of 513,284 confirmed COVID-19 cases and a comparison with 489,871 people receiving a COVID-19 mRNA vaccine
(2021-04)
Objectives To estimate the absolute risk of cerebral venous thrombosis (CVT) and portal vein thrombosis (PVT) in the two weeks following a diagnosis of COVID-19, and to assess the relative risks (RR) compared to influenza ...